Navigation Links
Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe
Date:12/3/2009

DALLAS, Dec. 3 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy. MuGard is commercially launched by Access' partner, SpePharm, in six European countries, including the UK, Germany, Italy, Norway, Greece and Sweden. Access is conducting pre-marketing activities, including ramping of commercial production, with the goal of a commercial launch in 1H 2010 in the US. MuGard was granted the CE mark certification in Europe in late 2008 with the labeling "prevention and management of the lesions and symptoms of oral mucositis." Key findings and feedback from SpePharm's ongoing commercial launch and patient assessment project include:

  • Over 15,000 bottles of MuGard have been used by over 2,000 patients since launch.
  • The European patient population includes adult patients undergoing radiotherapy and/or chemotherapy regimens.
  • Patients experience includes those being prescribed and using MuGard prophylactically, as well as those using MuGard following the onset of oral mucositis.
  • Initial feedback continues to reflect that MuGard is well accepted by both patients and healthcare professionals both as a preventative and curative treatment for oral mucositis.
  • Patients and healthcare professionals like MuGard's ready-to-use formulation, and believe it supports treatment compliance by patients.
  • SpePharm is currently gathering feedback from clinicians in the UK, Germany and Italy that are participating in a patient assessment project. SpePharm expects that out of a total of approximately 1,500 patients who will be given MuGard in this project, a consistent number of patient forms will be collected by year end, and th
    '/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Investor Relations Firm Access IR/PR and The Communications Strategy Group Announce Strategic Alliance
2. avVaa World Health Care Products Inc. Announces Access via Social Media Websites
3. Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan
4. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
5. NuAire Laboratory Economic Stimulus Package -- Free Accessories or Factory Options
6. One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions
7. Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights
8. Access Pharmaceuticals CEO Interviewed on Financial Website
9. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
10. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
11. Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Ariz., Aug. 27 MedPredict has published a,new ... Insight &,Analysis: Breast Cancer," designed to provide critical ... stake in the market for diagnostics,and treatments in ... European breast cancer thought leaders to identify the ...
... are urged to put auto-injectable ... the school supplies list, SILVER SPRING, Md., Aug. 27 ... Nurses (NASN) found that 72% of school,nurses have students with ... parents have not provided the school with auto-injectable,epinephrine. Also known ...
... Aug. 27 MDdatacor, Inc., a leader in ... providers, announced,today that CMS has approved the company ... Medicaid Services (CMS)., MDdatacor will automate the ... the administrative burden of having to,hand-write data collection ...
Cached Biology Technology:Pipeline for Breast Cancer Therapies is Focus of New MedPredict Report 2Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 2Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 3Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 4MDdatacor Designated as Approved Vendor by CMS for Physician Quality Reporting Initiative 2
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... is one of many important crop species that is ... commonly used to work with crops. Researchers, reporting in ... the first high-throughput forward and reverse genetics tool for ... crop breeders around the world.. Researchers from the ...
... years fifth annual Bonefish Population Census in the Florida ... from 2006, however, the number of volunteers participating in ... Ault, Ph.D., University of Miami Rosenstiel School of Marine ... thats exactly the type of fish stock numbers and ...
... 2008 -- A team of scientists led by Washington University ... of corn, a crop vital to U.S. agriculture. The researchers ... accomplishment that should accelerate efforts to develop better crop varieties ... fuel. , Corn, also known as maize, underlies myriads ...
Cached Biology News:Scientists unravel the genetic coding of the pea 25th annual Keys bonefish population census results announced 2Washington University unveils draft sequence of corn genome 2Washington University unveils draft sequence of corn genome 3
... between P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) ... the lumenal surface of endothelial cells at ... primary role of PSGL-1 in mediating the ... well documented.MAB4092 completely blocks recognition of PSGL-1 ...
Mouse Anti-Human MCAF-(MCP-1)...
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
Biology Products: